Trial Profile
Clinical Trials Insight: 700058583
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2010
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 19 Aug 2010 This trial is expected to be initiated in the third quarter of 2010, according to a Curaxis Pharmaceutical media release.
- 19 Aug 2010 New trial record